Bank of Montreal
AVXL icon

Bank of Montreal’s Anavex Life Sciences AVXL Stock Holding History

Bank of Montreal’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-24,100
Closed -$74K – 4849
2019
Q1 		$74K Hold
24,100
– – ﹤0.01% 3193
2018
Q4 		$38K Buy
+24,100
New +$54.7K ﹤0.01% 3390
2017
Q3 		– Sell
-75,000
Closed -$399K – 4151
2017
Q2 		$399K Hold
75,000
– – ﹤0.01% 2364
2017
Q1 		$431K Buy
+75,000
New +$387K ﹤0.01% 2152
2016
Q4 		– Sell
-36,100
Closed -$131K – 4043
2016
Q3 		$131K Buy
+36,100
New +$152K ﹤0.01% 2633

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of Montreal's AVXL Position: Q1 2026 in Review

Bank of Montreal increased its Anavex Life Sciences (AVXL) stake by 25% in Q1 2026, buying an estimated $35.7K and bringing the position to 40,693 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

Bank of Montreal first reported a position in AVXL in Q4 2015 and has held it in 35 quarters since. The position peaked at $442K in Q1 2017. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Bank of Montreal held 40,693 shares of Anavex Life Sciences worth $125K as of Q1 2026.
  • Bank of Montreal bought 8,253 Anavex Life Sciences shares in Q1 2026, an estimated $35.7K.
  • Anavex Life Sciences made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3076 holding.
  • Bank of Montreal first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 35 quarters since.
  • Bank of Montreal's Anavex Life Sciences position peaked at $442K in Q1 2017.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.